分娩时如何减少合成催产素的使用,刺激内源性催产素的产生

IF 0.3 Q4 PEDIATRICS
A. Ragusa
{"title":"分娩时如何减少合成催产素的使用,刺激内源性催产素的产生","authors":"A. Ragusa","doi":"10.7363/040228","DOIUrl":null,"url":null,"abstract":"The purpose of this review is to examine synthetic and natural oxytocin use in pregnancy and post-partum. We distinguished synthetic oxytocin (Syntocinon®) use in labor as a uterine contraction stimulant in two parts: the first is for induction or augmentation of labor; the second for prevention of post-partum hemorrhage (PPH).Oxytocin, key hormone in the process of childbirth and lactation, is a strong smooth muscle stimulant. For this reason it is widely used to induce/augment labor and to prevent and cure PPH.However, Syntocinon® can penetrate the placenta and reach fetal circulation, thus causing various systemic effects on mother and fetus. Oxytocin plays an important role as a neurotransmitter in the central nervous system, affecting numerous neuro-behavioral functions and it is involved in many types of parental behavior in humans and animals. It is, in fact, involved in a wide variety of physiological and pathological functions such as sexual activity, penile erection, ejaculation, pregnancy, uterus contractions, milk ejection, maternal behavior, social bonding, and stress. Oxytocin has a decisive role in the process of “bonding” between mother and child and in that of social affiliation.We therefore explored the opportunity to reduce the use of Syntocinon® in labor ward as a precautionary measure.Finally, we place the emphasis on some techniques that will probably increase the production of endogenous oxytocin. Proceedings of the 11th International Workshop on Neonatology and Satellite Meetings · Cagliari (Italy) · October 26th-31st, 2015 · From the womb to the adultGuest Editors: Vassilios Fanos (Cagliari, Italy), Michele Mussap (Genoa, Italy), Antonio Del Vecchio (Bari, Italy), Bo Sun (Shanghai, China), Dorret I. Boomsma (Amsterdam, the Netherlands), Gavino Faa (Cagliari, Italy), Antonio Giordano (Philadelphia, USA)","PeriodicalId":51914,"journal":{"name":"Journal of Pediatric and Neonatal Individualized Medicine","volume":"4 1","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2015-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"How to reduce synthetic oxytocin administration and stimulate the production of endogenous oxytocin in childbirth\",\"authors\":\"A. Ragusa\",\"doi\":\"10.7363/040228\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The purpose of this review is to examine synthetic and natural oxytocin use in pregnancy and post-partum. We distinguished synthetic oxytocin (Syntocinon®) use in labor as a uterine contraction stimulant in two parts: the first is for induction or augmentation of labor; the second for prevention of post-partum hemorrhage (PPH).Oxytocin, key hormone in the process of childbirth and lactation, is a strong smooth muscle stimulant. For this reason it is widely used to induce/augment labor and to prevent and cure PPH.However, Syntocinon® can penetrate the placenta and reach fetal circulation, thus causing various systemic effects on mother and fetus. Oxytocin plays an important role as a neurotransmitter in the central nervous system, affecting numerous neuro-behavioral functions and it is involved in many types of parental behavior in humans and animals. It is, in fact, involved in a wide variety of physiological and pathological functions such as sexual activity, penile erection, ejaculation, pregnancy, uterus contractions, milk ejection, maternal behavior, social bonding, and stress. Oxytocin has a decisive role in the process of “bonding” between mother and child and in that of social affiliation.We therefore explored the opportunity to reduce the use of Syntocinon® in labor ward as a precautionary measure.Finally, we place the emphasis on some techniques that will probably increase the production of endogenous oxytocin. Proceedings of the 11th International Workshop on Neonatology and Satellite Meetings · Cagliari (Italy) · October 26th-31st, 2015 · From the womb to the adultGuest Editors: Vassilios Fanos (Cagliari, Italy), Michele Mussap (Genoa, Italy), Antonio Del Vecchio (Bari, Italy), Bo Sun (Shanghai, China), Dorret I. Boomsma (Amsterdam, the Netherlands), Gavino Faa (Cagliari, Italy), Antonio Giordano (Philadelphia, USA)\",\"PeriodicalId\":51914,\"journal\":{\"name\":\"Journal of Pediatric and Neonatal Individualized Medicine\",\"volume\":\"4 1\",\"pages\":\"\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2015-10-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pediatric and Neonatal Individualized Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7363/040228\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric and Neonatal Individualized Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7363/040228","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 1

摘要

本综述的目的是检查合成和天然催产素在妊娠和产后的使用。我们区分合成催产素(Syntocinon®)在分娩中作为子宫收缩兴奋剂的使用分为两部分:第一是用于诱导或增强分娩;二是预防产后出血(PPH)。催产素是分娩和哺乳过程中的关键激素,是一种强效平滑肌兴奋剂。因此,它被广泛用于诱导/促进分娩和预防和治疗PPH。然而,Syntocinon®可以穿透胎盘,进入胎儿循环,从而对母亲和胎儿造成各种系统影响。催产素在中枢神经系统中作为一种神经递质发挥着重要作用,影响着许多神经行为功能,并与人类和动物的许多类型的亲代行为有关。事实上,它涉及到各种生理和病理功能,如性活动、阴茎勃起、射精、怀孕、子宫收缩、乳汁喷射、母性行为、社会关系和压力。催产素在母亲和孩子之间的“结合”过程和社会关系中起着决定性的作用。因此,我们探索了减少Syntocinon®作为预防措施在产房使用的机会。最后,我们将重点放在一些可能会增加内源性催产素产生的技术上。第11届国际新生儿学与卫星会议论稿·卡利亚里(意大利)·2015年10月26 -31日·从子宫到成人特约编辑:Vassilios Fanos(意大利卡利亚里),Michele Mussap(意大利热那亚),Antonio Del Vecchio(意大利巴里),Bo Sun(中国上海),Dorret I. Boomsma(荷兰阿姆斯特丹),Gavino Faa(意大利卡利亚里),Antonio Giordano(美国费城)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
How to reduce synthetic oxytocin administration and stimulate the production of endogenous oxytocin in childbirth
The purpose of this review is to examine synthetic and natural oxytocin use in pregnancy and post-partum. We distinguished synthetic oxytocin (Syntocinon®) use in labor as a uterine contraction stimulant in two parts: the first is for induction or augmentation of labor; the second for prevention of post-partum hemorrhage (PPH).Oxytocin, key hormone in the process of childbirth and lactation, is a strong smooth muscle stimulant. For this reason it is widely used to induce/augment labor and to prevent and cure PPH.However, Syntocinon® can penetrate the placenta and reach fetal circulation, thus causing various systemic effects on mother and fetus. Oxytocin plays an important role as a neurotransmitter in the central nervous system, affecting numerous neuro-behavioral functions and it is involved in many types of parental behavior in humans and animals. It is, in fact, involved in a wide variety of physiological and pathological functions such as sexual activity, penile erection, ejaculation, pregnancy, uterus contractions, milk ejection, maternal behavior, social bonding, and stress. Oxytocin has a decisive role in the process of “bonding” between mother and child and in that of social affiliation.We therefore explored the opportunity to reduce the use of Syntocinon® in labor ward as a precautionary measure.Finally, we place the emphasis on some techniques that will probably increase the production of endogenous oxytocin. Proceedings of the 11th International Workshop on Neonatology and Satellite Meetings · Cagliari (Italy) · October 26th-31st, 2015 · From the womb to the adultGuest Editors: Vassilios Fanos (Cagliari, Italy), Michele Mussap (Genoa, Italy), Antonio Del Vecchio (Bari, Italy), Bo Sun (Shanghai, China), Dorret I. Boomsma (Amsterdam, the Netherlands), Gavino Faa (Cagliari, Italy), Antonio Giordano (Philadelphia, USA)
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.00
自引率
25.00%
发文量
0
审稿时长
12 weeks
期刊介绍: The Journal of Pediatric and Neonatal Individualized Medicine (JPNIM) is a peer-reviewed interdisciplinary journal which provides a forum on new perspectives in pediatric and neonatal medicine. The aim is to discuss and to bring readers up to date on the latest in research and clinical pediatrics and neonatology. Special emphasis is on developmental origin of health and disease or perinatal programming and on the so-called ‘-omic’ sciences. Systems medicine blazes a revolutionary trail from reductionist to holistic medicine, from descriptive medicine to predictive medicine, from an epidemiological perspective to a personalized approach. The journal will be relevance to clinicians and researchers concerned with personalized care for the newborn and child. Also medical humanities will be considered in a tailored way. Article submission (original research, review papers, invited editorials and clinical cases) will be considered in the following fields: fetal medicine, perinatology, neonatology, pediatrics, developmental programming, psychology and medical humanities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信